Predicting need for allogeneic transfusion after total knee arthroplasty
- PMID: 22608172
- DOI: 10.1016/j.arth.2011.10.008
Predicting need for allogeneic transfusion after total knee arthroplasty
Abstract
Total knee arthroplasty (TKA) can lead to substantial blood loss. To avoid the high costs of autologous blood predonation programs and efficiently allocate limited blood resources, we sought to identify preoperative and intraoperative factors associated with allogeneic blood transfusion (AllTx) after primary TKA and, subsequently, develop a model to predict patients who will require AllTx. We analyzed 31 independent variables in 644 primary unilateral TKAs without autologous blood predonation for requirement of AllTx. Seventy-one procedures (11.0%) required AllTx. Age, comorbid anemia, preoperative hemoglobin concentration, and surgical time were significant predictors for requiring AllTx. When applied to an independent cohort, our model for predicting the need for AllTx after TKA was 90% sensitive and 52.5% specific.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Blood transfusion requirement prediction in patients undergoing primary total hip and knee arthroplasty.Transfus Med. 2007 Feb;17(1):37-43. doi: 10.1111/j.1365-3148.2006.00698.x. Transfus Med. 2007. PMID: 17266702
-
The effect of computer navigation on blood loss and transfusion rate in TKA.Orthopedics. 2010 Jul 13;33(7):474. doi: 10.3928/01477447-20100526-08. Orthopedics. 2010. PMID: 20608630
-
Autologous blood donation and subsequent blood use in patients undergoing total knee arthroplasty.Transfus Med. 2006 Oct;16(5):313-9. doi: 10.1111/j.1365-3148.2006.00701.x. Transfus Med. 2006. PMID: 16999753
-
A model for predicting transfusion requirements in head and neck surgery.Laryngoscope. 1995 Aug;105(8 Pt 2 Suppl 73):1-17. doi: 10.1288/00005537-199508001-00001. Laryngoscope. 1995. PMID: 7630307 Review.
-
Use of donor blood in the surgical setting potentials for application of blood substitutes.Artif Cells Blood Substit Immobil Biotechnol. 1997 Jan-Mar;25(1-2):25-9. doi: 10.3109/10731199709118894. Artif Cells Blood Substit Immobil Biotechnol. 1997. PMID: 9083623 Review.
Cited by
-
Optimizing Intraoperative Blood Management for One-Stage Bilateral Total Knee Arthroplasty.HSS J. 2018 Jul;14(2):202-210. doi: 10.1007/s11420-017-9590-4. Epub 2017 Dec 7. HSS J. 2018. PMID: 29983664 Free PMC article. Review.
-
Low Dose Perioperative Intravenous Tranexamic Acid in Patients Undergoing Total Knee Arthroplasty: A Double-Blind Randomized Placebo Controlled Clinical Trial.J Blood Transfus. 2015;2015:948304. doi: 10.1155/2015/948304. Epub 2015 Dec 6. J Blood Transfus. 2015. PMID: 26770871 Free PMC article.
-
Predictive Factors for Blood Transfusion after Total Knee Arthroplasty.Rev Bras Ortop (Sao Paulo). 2021 Aug;56(4):463-469. doi: 10.1055/s-0040-1715511. Epub 2020 Nov 2. Rev Bras Ortop (Sao Paulo). 2021. PMID: 34483390 Free PMC article.
-
Total knee Arthroplasty: risk factors for allogeneic blood transfusions in the South Asian population.BMC Musculoskelet Disord. 2017 Aug 23;18(1):359. doi: 10.1186/s12891-017-1728-5. BMC Musculoskelet Disord. 2017. PMID: 28830388 Free PMC article.
-
Comparison of intravenous and topical tranexamic acid in total knee arthroplasty.BMC Musculoskelet Disord. 2018 Jun 13;19(1):191. doi: 10.1186/s12891-018-2122-7. BMC Musculoskelet Disord. 2018. PMID: 29898707 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical